At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Nutritional Biomarkers of Sarcopenia
In Brief
A clinical study evaluating XS Muscle Multiplier for Sarcopenia. Completed, enrolled 30 participants across 1 site.
Detailed Summary
This study proposes to characterize skeletal muscle amino acid kinetics to an EAA challenge, i.e., an oral amino acid tolerance test (OATT), in order to determine the state of muscle health. Analogous to the oral glucose tolerance test (OGTT) used to characterize alterations in glucose metabolism, the proposed OATT represents a potential low-cost solution to classifying patients' skeletal muscle health. The extrapolation of this work is the development of a simple analytical tool that would provide clinicians the ability to discern alterations in muscle amino acid kinetics prior to a loss of function.
Study Details
Timeline
Interventions
Distributed by Amway; this product is a powder, sold in a 6.8 ounce (192g) container.